期刊文献+

促红细胞生成素诱导骨髓内皮祖细胞功能活化与JAK2依赖ERK信号途径的作用 被引量:3

Effects of JAK2-dependent ERK signal pathway on erythropoietin-induced functional activation of bone marrow-derived endothelial progenitor cells
下载PDF
导出
摘要 背景:促红细胞生成素能够促进内皮细胞增殖、迁延,形成新生血管,因此促红细胞生成素可能诱导内皮祖细胞功能活化。除了经典的造血功能以外,是否内皮祖细胞也是促红细胞生成素促血管生成效应的一个靶点。目的:观察促红细胞生成素对大鼠骨髓内皮祖细胞功能活性的影响,并分析其信号途径。方法:用密度梯度离心法分离大鼠骨髓内皮祖细胞。首先将细胞分为无血清DMEM培养液对照组、重组人促红细胞生成素500,1000,2000U/L组、促红细胞生成素(2000U/L)与ERK抑制剂FR180204(50μmol/L)共同作用组,分别用MTT比色法、Transwell小室、Matrigel、Westernblot法检测内皮祖细胞的增殖活性、迁移、管腔形成能力及Bcl-2表达。然后将细胞分为无血清DMEM培养液对照组、重组人促红细胞生成素组2000U/L组,促红细胞生成素(2000U/L)与JAK2抑制剂SD1029(10μmol/L)共同作用组,用Westernblot法检测P-ERK的表达。结果与结论:与对照组相比,随着浓度的增加,促红细胞生成素可明显增强内皮祖细胞的增殖活性,增加迁移的细胞数及形成的管腔数,上调Bcl-2蛋白的表达,在一定范围内呈剂量依赖效应。当加入ERK抑制剂FR180204后,与促红细胞生成素2000U/L组相比,这些效应明显减弱。此外,促红细胞生成素上调p-ERK1/2的表达,当加入JAK2抑制剂SD1029后,p-ERK1/2的表达明显下调。提示促红细胞生成素能够促进内皮祖细胞功能活化,这种效应可能是通过依赖JAK2的ERK信号途径调节的。 BACKGROUND:Erythropoietin(EPO) can promote the proliferation and migration of endothelial cells to form new vessels,so EPO may play an important role in functional activation of endothelial progenitor cells(EPCs).Except hematopoiesis,whether EPCs are a target of EPO remains poorly understood.OBJECTIVE:To investigate the effects of EPO on functional activation of EPCs and its signal pathway.METHODS:EPCs were separated from bone marrow of rats using density gradient centrifugation.First,cells were divided into control group(serum-free DMEM culture medium),recombinant human erythropoietin(rhEPO) in different dose groups(500,1 000,2 000 U/L),EPO(2 000 U/L) and the ERK inhibitor FR180204(50 μmol/L) interaction group.Proliferation,migration,tubes formation and Bcl-2 expression of EPCs were detected with MTT assay,Transwell chamber,Matrigel and Western blot assay respectively.Secondly,cells were divided into control group(serum-free DMEM culture medium),rhEPO group(2 000 U/L),rhEPO(2 000 U/L) and JAK2 inhibitor SD1029(10 μmol/L) interaction group.P-ERK expression of EPCs was detected by Western blot assay.RESULTS AND CONCLUSION:Compared with control group,EPO significantly increased EPCs proliferation,the number of migrating cells and tubes formation,up-regulated Bcl-2 protein expression in a dose-dependent manner in a certain rage.After added ERK inhibitor FR180204,these effects were significantly decreased compared with the rhEPO group(2 000 U/L).In addition,compared with the control group,the p-ERK1/2 expression in the rhEPO group(2000 U/L) was significantly up-regulated,JAK2 inhibitor SD1029 made the result reduced markedly.These indicate that EPO can promote functional activity of EPCs,which might be modulated by JAK2-dependent ERK signal pathway.
作者 赵薇 杨向红
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2010年第49期9203-9207,共5页 Journal of Clinical Rehabilitative Tissue Engineering Research
  • 相关文献

参考文献22

  • 1Raddino R,Robba D,Caretta G,et al.Erythropoietin:a new perspective in cardiovascular therapy.Monaldi Arch Chest Dis.2008;70(4):206-213.
  • 2Koul D,Dhar S,Chen-Scarabelli C,et al.Erythropoietin:new horizon in cardiovascular medicine.Recent Pat Cardiovasc Drug Discov.2007;2(1):5-12.
  • 3Lipsic E,Schoemaker RG,van der Meer P,et al.Protective effects of erythropoietin in cardiac ischemia:from bench to bedside.J Am Coil Cardiol.2006;48(11):2161-2167.
  • 4Ghezzi P,Brines M.Erythropoietin as an antiapoptotic,tissueprotective cytokine.Cell Death Differ.2004;11(Suppl 1):S37-44.
  • 5Li F,Chong ZZ,Maiese K.Erythropoietin on a tightrope:balancing neuronal and vascular protection between intrinsic and extrinsic pathways.Neurosignals.2004;13(6):265-289.
  • 6Lappin T.The cellular biology of erythropoietin receptors.Oncologist.2003;8(Suppl 1):15-18.
  • 7Maiese K,Li F,Chong ZZ.Erythropoietin in the brain:can the promise to protect be fulfilled? Trends Pharmacol Sci.2004;25(11):577-583.
  • 8Maiese K,Li F,Chong ZZ.New avenues of exploration for erythropoietin.JAMA.2005;293 (1):90-95.
  • 9Ogilvie M,Yu X,Nicolas-Metral V,et al.Erythropoietin stimulates proliferation and interferes with differentiation of myoblasts.J Biol Chem.2000;275(50):39754-39761.
  • 10Sachinidis A,Kolossov E,Fleischmann BK,et al.Generation of cardiomyocytes from embryonic stem cells experimental studies.Herz.2002;27(7):589-597.

二级参考文献8

  • 1胡野荣,邓又华,姜志斌,吴忠仕.人脐静脉内皮细胞体外分离培养的改进及其鉴定[J].医学临床研究,2005,22(5):587-589. 被引量:14
  • 2Anagnostou A, Liu Z, Steiner M, et al. Erythropoietin receptor mRNA expression in humen endothelial cells[J]. Proc Natl Acad Sci USA, 1994,91(9) :3974-3978.
  • 3Carlini R, Reyca A, Rothatcin M. Recombiant human erythropoietin stimulates angiogenesis in vito[J]. Kindey Int, 2006,47 (4) 740-745.
  • 4Maga G, Hubscher U. Proliferating cell nuclear antigen (PCNA):a dancer with many partners [J]. J Cell Sci, 2003, 116 (15):3051-3060.
  • 5Duman-Scheel M, Weng L, Xin S, et al. Hedgehog regulates cell growt h and proliferation by inducing cyclin D and cyelin E[J]. Nature, 2002,417(6886) :299-304.
  • 6Serrabi Nm, Gabbib G J, Beach D A. A new regulatory modified in cell cycle control causing specific inhibition of cyclin D/CDk4[J]. Nature, 1993,366(6456) :704-707.
  • 7Heeschen C, Aicher A, Lehmann R, et al. Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization [J]. Blood, 2003,102(4) : 1340-1346.
  • 8Jaquet K, Krause K, Tawakol-Khodai M, et al. Erythropoietin and VEGF exhibit equal angiogenic potential[J]. Microvasc Res, 2002,64(2) :326 333.

共引文献709

同被引文献21

  • 1Huang GT, Gronthos S, Shi S. Mesenchymal stem cells de- rived from dental tissues vs. those from other sources: Their biology and role in regenerative medicine [ J ]. J Dent Res, 2009, 88(9) :792 -806.
  • 2Gong Q, Jiang H, Wei X, et al. Expression of erythropoie- tin and erythropoietin receptor in human dental pulp [ J ]. J Endod, 2010, 36(12) : 1972 - 1977.
  • 3Noguchi CT, Asavaritikrai P, Teng R, et al. Role of eryth- ropoietin in the brain [ J ]. Crit Rev Oncol Hematol, 2007, 64(2) :159 - 171.
  • 4Cho GW, Koh SH, Kim MH, et al. The neuroprotective effect of erythropoietin-transduced human mesenchymal stro- mal cells in an animal model of ischemic stroke [ J]. Brain Res, 2010, 1353:1 - 13.
  • 5Rodriguez-Lozano FJ, Bueno C, Insausti CL, et al. Mesen-chymal stem cells derived from dental tissues[ J]. Int Endod J, 2011,44(9) :800 -806.
  • 6A1-Sharabi N, Xue Y, Fujio M, et al. Bone marrow stromal cell paracrine factors direct osteo/odontogenic differentiation of dental pulp cells[J]. Tissue Eng Part A, 2014, 20(21 - 22) :3063 - 3072.
  • 7Papagerakis P, Berdal A, Mesbah M, et al. Investigation of osteocalcin, osteonectin, and dentin sialophosphoprotein in developing human teeth [ J ]. Bone, 2002, 30 (2) : 377 - 385.
  • 8Nakashima K, Zhou X, Knnkel G, et al. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation [ J]. Cell, 2002, 108(1):17 -29.differentiation and dentin formation [ J ]. Biochem Biophys Res Commun, 2011,410(3) :698 -704.
  • 9Li S, Kong H, Yao N, et al. The role of runt-related tran- scription factor 2 (Runx2) in the late stage of odontoblast.
  • 10段爱华.促红细胞生成素的研究进展[J].中国全科医学,2008,11(3):264-267. 被引量:16

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部